Wiskott–Aldrich syndrome

New findings indicate that gene therapy continues to provide sustained benefit for patients with Wiskott–Aldrich syndrome, a rare inherited immune disorder. The results suggest the one-time treatment can offer long-lasting improvement in immune function, offering hope to families affected by the condition, which historically has been managed with transplants or supportive care.